06Oct 2022
The Efficacy and Safety of Abaloparatide‐SC in Men with Osteoporosis: A Randomized Clinical Trial

The Efficacy and Safety of Abaloparatide‐SC in Men with Osteoporosis: A Randomized Clinical Trial

Abaloparatide significantly increased bone mineral density (BMD) in women with postmenopausal osteoporosis, and decreased risk of vertebral, nonvertebral, and clinical fractures compared with placebo. The primary endpoint was change from baseline in lumbar spine BMD. These results suggest abaloparatide can be considered as an effective anabolic treatment option for men with osteoporosis.

  • #orthopaedics

Like

Save

Share